Patent intelligence · WO
WO 2009084970
3-N-PHÉNYL-1,3,4-OXADIAZOLONES 5-O-SUBSTITUÉES POUR UNE UTILISATION MÉDICALE
3-N-PHÉNYL-1,3,4-OXADIAZOLONES 5-O-SUBSTITUÉES POUR UNE UTILISATION MÉDICALE
Patent details — WO 2009084970
- Jurisdiction
- WO
- Status
- granted
- Grant date
- Jul 9, 2009
- Expiration
- Jul 4, 2029
- Applicant
- BIAL PORTELA & COMPANHIA S A [PT]
- CPC classes
- A61K 31/ 4245 A I, A61P 9/ 00 A I, A61P 11/ 00 A I, A61P 25/ 00 A I
Quick answer
WO 2009084970 (3-N-PHÉNYL-1,3,4-OXADIAZOLONES 5-O-SUBSTITUÉES POUR UNE UTILISATION MÉDICALE) is held by BIAL PORTELA & COMPANHIA S A [PT]. Status: granted. Granted Jul 9, 2009. Expires Jul 4, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIAL PORTELA & COMPANHIA S A [PT]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 4245 A I, A61P 9/ 00 A I, A61P 11/ 00 A I, A61P 25/ 00 A I, A61P/100, A61P/104
More from BIAL PORTELA & COMPANHIA S A [PT]
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 2009084970?
WO 2009084970 (3-N-PHÉNYL-1,3,4-OXADIAZOLONES 5-O-SUBSTITUÉES POUR UNE UTILISATION MÉDICALE) is held by BIAL PORTELA & COMPANHIA S A [PT]. Status: granted. Granted Jul 9, 2009. Expires Jul 4, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Who owns WO 2009084970?
BIAL PORTELA & COMPANHIA S A [PT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3 pharmaceutical patents for this assignee.
When does WO 2009084970 expire?
Our index shows an expiration date of Jul 4, 2029 (3 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.